about
HIV-associated neurocognitive disorder--pathogenesis and prospects for treatmentProgressive Multifocal Leukoencephalopathy in HIV-Uninfected Individuals.Speaking the same language: Cross-sectional assessment of perceived contributors to professionalism across generations.Acute encephalitis in the immunocompromised individual.Peripheral neuropathy in HIV-infected and uninfected patients in Rakai, Uganda.Pneumocystis jiroveci pneumonia in rheumatic disease: a 20-year single-centre experience.Comparative Outcomes in Children and Adults With Anti- N-Methyl-D-Aspartate (anti-NMDA) Receptor Encephalitis.Evidence for the Importance of Vitamin D Status in Neurologic Conditions.Treatment of human immunodeficiency virus-related peripheral neuropathy with Scrambler Therapy: a case report.Neurobehavioral outcomes in autoimmune encephalitis.Emergency Department MRI Scanning of Patients with Multiple Sclerosis: Worthwhile or Wasteful?Global HIV neurology: a comprehensive review.Multiple sclerosis and HIV: a case of multiple sclerosis-immune reconstitution inflammatory syndrome associated with antiretroviral therapy initiation.Follow-Up of Emergency Department MRI Scans Suggesting New Diagnosis of CNS Demyelination.Global Neurology: Navigating Career Possibilities.HIV-associated neurocognitive disorder - pathogenesis and prospects for treatment.Neurologic Complications of Human Immunodeficiency Virus InfectionAcute progressive paraplegia in heroin-associated myelopathyThe Global Burden of HeadacheSpontaneous intracerebral hemorrhage in West Africa: A call to actionCaregiver versus self-reported activities of daily living among HIV-positive persons in Rakai, UgandaHeadache prevalence and its functional impact among HIV-infected adults in rural Rakai District, UgandaVitamin D is not associated with HIV-associated neurocognitive disorder in Rakai, UgandaThe Veterans Aging Cohort Study Index is not associated with HIV-associated neurocognitive disorders in UgandaInterleukin-6 is associated with mortality and neuropsychiatric outcomes in antiretroviral-naïve adults in Rakai, Uganda
P50
Q26766448-B602FA38-2088-4E1F-8F98-E34E27F85D3EQ30245002-AAA01565-C52E-42CE-AC80-204DFAC42606Q37008827-0B5C557F-3A00-4948-9DF2-D1D1F5747BD2Q38534206-3A0F9C7F-0E7D-4FB7-BD2A-1F68725F869BQ38849779-CB37EFAE-7173-4875-B491-8504CA900655Q38992555-B96FB18C-B1E4-4DAB-85F3-5D3A851E9B62Q39450024-FD8098E1-5175-4C8D-A62F-63C01BFD52B4Q40354703-753B6BB6-20E1-4B06-AC96-4096B36758E2Q40688588-BC89D413-0D7C-49EE-B3B4-EA86BF864DD4Q47625595-F9CCCA90-BAD6-4CFF-9E64-66534A2A54C5Q48290435-40D54735-C035-4983-9A1B-C8090D9461C1Q51762497-B06E594A-CB5A-49A7-BA32-02AF67C5253FQ52691786-FED27B75-97EA-4BDF-AD79-8CF48FC44357Q53319216-42D717FD-3D6A-4BF1-8064-97A6500B0471Q54558119-7D553D13-81DA-439B-932C-D287C0229DF5Q55135038-E6659D20-F95E-468B-BEED-A95C13E7D1F6Q57054115-CFB978C4-B3A5-4841-8572-C5C1F1E9E970Q87887031-4A0AF199-0F03-45A4-9614-8DD6C8784C4AQ88786086-69C180EE-CED0-4576-9B76-44BA12A237DFQ89789811-7B4DEF27-A576-4540-A4E3-01E754E86764Q90565428-0E367ED4-1FDC-493E-AFD5-045C6F856F51Q90875297-2EBB1441-471C-4958-AD7E-92E4FFAB40ECQ91172975-209FC728-AEA8-445E-9725-C64581F68BCCQ91265285-85A74D7E-43A3-4B9B-8430-47893CD690A4Q92529654-FB69D7EF-C557-432B-AAC5-7315BA402F43
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
D Saylor
@ast
D Saylor
@en
D Saylor
@es
D Saylor
@nl
type
label
D Saylor
@ast
D Saylor
@en
D Saylor
@es
D Saylor
@nl
prefLabel
D Saylor
@ast
D Saylor
@en
D Saylor
@es
D Saylor
@nl
P106
P31
P496
0000-0002-9297-0244